Patent · US Active

Tissue ablation with irreversible electroporation

US9005189B2 · kind B2 · utility

137Cited by
109References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2012
Grant dateApr 14, 2015
Priority date
Expiry dateJul 11, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/327
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.